Drug Shortage Report for CERETEC
| Report ID | 260853 |
| Drug Identification Number | 02484048 |
| Brand name | CERETEC |
| Common or Proper name | Kit for the Preparation of Technetium-99m Exametazime Injection |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | EXAMETAZIME |
| Strength(s) | 0.5MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 vial kit |
| ATC code | V09HA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-09-01 |
| Actual start date | |
| Estimated end date | 2025-10-24 |
| Actual end date | 2025-06-23 |
| Shortage status | Avoided shortage |
| Updated date | 2025-06-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-06-23 | French | Compare |
| v3 | 2025-06-23 | English | Compare |
| v2 | 2025-06-20 | French | Compare |
| v1 | 2025-06-20 | English | Compare |
Showing 1 to 4 of 4